Her research focuses on optimization of currently available treatments for rheumatic diseases, in particular gout and rheumatoid arthritis. Her clinical research includes clinical trials, pharmacokinetic and pharmacogenetic studies particularly related to allopurinol, the most commonly used urate lowering therapy for gout and methotrexate, the anchor drug in the management of rheumatoid arthritis and the newer biological therapies.